In announcing the latest increase to TrumpRx, President Donald Trump framed the change as both a response to criticism of the government-backed discount initiative and an effort to target a persistent political concern ahead of November’s midterm elections: the affordability of health care. Speaking at a White House event, Trump said the website, which is positioned to help people find lower-cost options for prescription drugs, would now include “more than 600 generic medications,” expanding the Trump administration’s offering beyond what it launched with earlier this year.

Trump said the TrumpRx expansion is made possible through partnerships with other online pharmacies, including Amazon Pharmacy, GoodRx and Mark Cuban’s Cost Plus Drugs. At the same time, he described the move as aimed at concerns raised by Democrats, who have argued that TrumpRx was largely performative and that many of the brand-name drugs it highlighted were cheaper with insurance or had lower-cost generic versions available elsewhere.

The White House described TrumpRx as a facilitator rather than a pharmacy platform itself. Under that model, TrumpRx points consumers to drugmakers’ direct-to-consumer websites where they can make purchases, and it also provides coupons intended for use at pharmacies. TrumpRx initially launched in February with over 40 medications, and Trump said Monday’s additions would increase the site’s offerings by nearly seven times.

Trump also said TrumpRx has been visited more than 10 million times since the site’s February launch. “’This has been the greatest breakthrough in lowering health care costs in modern history, but we’re just sort of getting started,’” Trump said at the event, calling TrumpRx the “hottest thing in medicine.”

Trump’s remarks about the generics expansion included the political and financial context he said is shaping voter concerns. The administration linked the move to affordability worries for many Americans, and to pressure on household budgets that it said has been compounded by recent Republican-led congressional cuts to Medicaid and the expiration of enhanced Affordable Care Act subsidies that raised some people’s premiums.

Rena Conti, a professor at Boston University’s Questrom School of Business, said in an interview that the savings potential from using TrumpRx depends heavily on a patient’s situation. Conti said that for most Americans who have health insurance, paying via that coverage for medications is usually a better deal than paying cash through TrumpRx. She said people who are uninsured or who face high deductibles to meet might benefit more from discounts on sites like TrumpRx, adding that the addition of generics would likely provide more options.

Mark Cuban attended the White House event alongside Trump. Cuban, who described himself as a political independent and who publicly campaigned for Democratic presidential nominee Kamala Harris in 2024, has also promoted TrumpRx and advocated for efforts within the U.S. Department of Health and Human Services to reduce prescription drug costs. Before Monday, Cuban had said that the main improvement Trump could make to TrumpRx would be to include drugs available on Cuban’s own site.

The coverage of the event also highlighted Cuban’s prior response to critics of TrumpRx, including a social media post in which Cuban wrote, “Everyone wants me to rip on TrumpRx,” adding that “Reality is, it’s saving patients money on IVF and a few other drugs. A lot of money.” Trump and Cuban presented their relationship in cordial terms during Monday’s announcement, with Trump saying, “We have the same thing, one thing in common: We want to make people better and keep them wealthy.”

Beyond TrumpRx, the administration has promoted other efforts to lower prescription drug costs. These include deals between Trump and the 17 major drugmakers to offer medications at prices that appear in other developed countries, or lower, though the AP reported that details of those deals have not been made public and have faced scrutiny from lawmakers of both parties who want to review the contracts.